# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE ONLY TEMPLATE

A. 510(k) Number:

k050182

# B. Purpose For Submission:

Premarket Notification 510(k) of intention to manufacture and market the Biomedix, Inc. Q. STEPS Biometer $\mathrm { G } / \mathrm { C }$ Dual Monitoring System

# C. Analyte:

Whole Blood Glucose Whole Blood Cholesterol

# D. Type of Test:

Quantitative, utilizing Glucose Oxidase technology.   
Quantitative, utilizing Cholesterol Oxidase technology.

# E. Applicant:

Biomedix, Inc.

# F. Proprietary and Established Names:

Q. STEPS™ Biometer $\mathrm { G } / \mathrm { C }$ Dual Monitoring System.

# G. Regulatory Information:

1. Regulation section:

<table><tr><td rowspan=1 colspan=1>RegulationNumber</td><td rowspan=1 colspan=1>Standard Product Nomenclature</td><td rowspan=1 colspan=1>Panel</td><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Class</td></tr><tr><td rowspan=1 colspan=1>862.1345</td><td rowspan=1 colspan=1>System, Test, Blood Glucose, OverThe Counter</td><td rowspan=1 colspan=1>Chemistry(75)</td><td rowspan=1 colspan=1>NBW</td><td rowspan=1 colspan=1>II</td></tr><tr><td rowspan=1 colspan=1>862.1345</td><td rowspan=1 colspan=1>Glucose Oxidase, Glucose</td><td rowspan=1 colspan=1>Chemistry(75)</td><td rowspan=1 colspan=1>CGA</td><td rowspan=1 colspan=1>II</td></tr><tr><td rowspan=1 colspan=1>862.1175</td><td rowspan=1 colspan=1>Enzymatic Esterase-Oxidase,Cholesterol</td><td rowspan=1 colspan=1>Chemistry(75)</td><td rowspan=1 colspan=1>CHH</td><td rowspan=1 colspan=1>I</td></tr><tr><td rowspan=1 colspan=1>862.1660</td><td rowspan=1 colspan=1>Single (Specified) Analyte Controls(Assayed and Unassayed)</td><td rowspan=1 colspan=1>Chemistry(75)</td><td rowspan=1 colspan=1>JX</td><td rowspan=1 colspan=1>I</td></tr></table>

# H. Intended Use:

1. Intended use(s): See Indications for use below.

2. Indication(s) for use: The Q. STEPS Biometer G/C Dual Monitoring System is intended for use with Q.STEPS Glucose and Cholesterol Test Strips with Q. STEPS Biometer $\mathrm { G } / \mathrm { C }$ by healthcare professionals and home users. Q. STEPS Biometer G/C System provides a quantitative measurement of Glucose and Cholesterol in whole blood from the fingertips. The Glucose measurements are used in helping the management of carbohydrate metabolism disorders including diabetes mellitus, idiopathic hypoglycemia and pancreatis islet cell tumors. Cholesterol measurements are used in the management of disorders involving excess cholesterol in the blood, lipid and lipoprotein metabolism disorders.

3. Special condition for use statement(s): Provides plasma equivalent results.

4. Special instrument Requirements: Q. STEPS Biometer G/C Dual Monitoring System.

# I. Device Description:

The Q. STEPS™ Biometer G/C Dual Monitoring System uses enzymatic electrochemical biosensor technology to measure whole blood glucose and cholesterol levels. When finger blood is applied to the test spot of the biosensor (test strip) a reduction-oxidation reaction occurs. The oxidase of D-Glucose or Cholesterol which is catalyzed by Glucose Oxidase or by Cholesterol Oxidase respectively, causes an electron transfer at the electrode (silver) surface; and therefore, the magnitude of the current produced is proportional to the glucose or cholesterol concentration in the blood. The Biometer G/C uses that current to quantify the glucose and the cholesterol levels in the blood, and then display on the readout of the monitor.

# J. Substantial Equivalence Information:

1. Predicate device name(s): One Touch Basic Blood Glucose Monitoring System PTS Panels Lipid Panel Test Strips

2. Predicate K number(s): k031472 k023558

3. Comparison with Predicate:

# Substantial Equivalence Comparison Glucose

Similarities   

<table><tr><td rowspan=1 colspan=3>Smnalres</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Devices k050182</td><td rowspan=1 colspan=1>Predicate k031472</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Q. STEPSTM Biometer G/C DualMonitoring System (GlucoseSide Sensor)Intended to be used withQ.STEPSTm Biometer G/C andQ. STEPSTm Glucose Test Stripsfor the quantitative measurementof glucose in fresh capillarywhole blood from the fingertip.For professionals and Diabetespatients use.</td><td rowspan=1 colspan=1>One Touch Basis SystemIntended to be used with OneTouch ® basic and OneTouch® Test Strips for thequantitative measurement ofglucose in fresh capillarywhole blood from fingertip.For professionals and Diabetespatients use.</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Based on Glucose Oxidaseoxidation reduction to convertglucose into gluconic acid.</td><td rowspan=1 colspan=1>Based on Glucose Oxidaseoxidation reduction to convertglucose into gluconic acid.</td></tr><tr><td rowspan=1 colspan=1>Labeling InstructionRegarding Response toUnusual Results</td><td rowspan=1 colspan=1>Test should be run with liquidquality control material, Q.STEPSTM Control Solutionwhenever a new vial of test stripis opened or unusual blood testresult is obtained.</td><td rowspan=1 colspan=1>Test should be run with liquidquality control material, OneTouch® Control Solutionwhenever a new vial of teststrip is opened or unusualblood test result is obtained.</td></tr><tr><td rowspan=1 colspan=1>Meter Functional Test</td><td rowspan=1 colspan=1>A check strip is provided toensure the system is workingproperly</td><td rowspan=1 colspan=1>A check strip is provided toensure the system is workingproperly</td></tr><tr><td rowspan=1 colspan=1>Test Strips StorageCondition</td><td rowspan=1 colspan=1>Must be stored in the originalvial with the cap tightly closed.Stored in a cool dry place notabove 86°F (36°C) and awayfrom heat and direct sunlight, notrefrigerated.</td><td rowspan=1 colspan=1>Must be stored in the originalvial with the cap tightlyclosed. Stored in a cool dryplace not above 86°F (36°C)and away from heat and directsunlight, not refrigerated.</td></tr><tr><td rowspan=1 colspan=1>Strip Shelf Life</td><td rowspan=1 colspan=1>After opening the vial, 4 months</td><td rowspan=1 colspan=1>After opening the vial, 4months</td></tr></table>

Differences   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Devices k050182</td><td rowspan=1 colspan=1>Predicate k031472</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Amperometric</td><td rowspan=1 colspan=1>Photometric</td></tr><tr><td rowspan=1 colspan=1>Test Recall Memory</td><td rowspan=1 colspan=1>99 test results</td><td rowspan=1 colspan=1>75 test results memorycapacity.</td></tr><tr><td rowspan=1 colspan=1>Blood Sample VolumeReaction Time</td><td rowspan=1 colspan=1>Minimum is 5ul/30 seconds</td><td rowspan=1 colspan=1>Minimum is 10 l / 45seconds</td></tr><tr><td rowspan=1 colspan=1>PhysicalCharacteristics</td><td rowspan=1 colspan=1>The test spot is on the side of thetest strip and is a shape of half-a-circle.</td><td rowspan=1 colspan=1>The test spot is on the centerof the test strip and is in theshape of a circle.</td></tr></table>

# Substantial Equivalence Comparison Cholesterol

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Devices k050182</td><td rowspan=1 colspan=1>Predicate k023558</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The Q. STEPSTm Test Strip isintended to measure cholesterolin whole blood on the G/C DualMonitoring System.For Professionals and Diabetespatients use.</td><td rowspan=1 colspan=1>The Lipid Panel Test Stripsare intended to measurecholesterol, HDL andtriglycerides in whole bloodon a BIOScanner Plus(CardioChek Brand) analyzer.For Professionals and homeuser.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Finger Whole Blood</td><td rowspan=1 colspan=1>Finger Whole Blood</td></tr><tr><td rowspan=1 colspan=1>Result Display</td><td rowspan=1 colspan=1>Directly displays results withoutrequiring calculation.</td><td rowspan=1 colspan=1>Directly displays resultswithout requiring calculation.</td></tr><tr><td rowspan=1 colspan=1>Enzymatic reaction</td><td rowspan=1 colspan=1>Cholesterol Oxidase and EsteraseReaction</td><td rowspan=1 colspan=1>Cholesterol Oxidase andEsterase Reaction</td></tr><tr><td rowspan=1 colspan=1>PhysicalCharacteristics</td><td rowspan=1 colspan=1>Test strip with circular spot</td><td rowspan=1 colspan=1>Test strip with circular spot</td></tr><tr><td rowspan=1 colspan=1>Calibration Chip</td><td rowspan=1 colspan=1>It contains a lot specificelectronically erasable,programmable read-only memory(EEPROM) chip in the samepackage with the strips. TheEEPROM chip has the curveinformation programmed into itand based on a multipoint curveand is established for each lot.The user inserts this chip into themeter with each new lot of teststrips.</td><td rowspan=1 colspan=1>It contains a lot specificelectronically erasable,programmable read-onlymemory (EEPROM) chip inthe same package with thestrips. The EEPROM chip hasthe curve informationprogrammed into it and basedon a multipoint curve and isestablished for each lot. Theuser inserts this chip into themeter with each new lot of teststrips.</td></tr><tr><td rowspan=1 colspan=1>Device Storage</td><td rowspan=1 colspan=1>2-30°C</td><td rowspan=1 colspan=1>2-30°℃</td></tr></table>

Differences   

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Devices k050182</td><td rowspan=1 colspan=1>Predicate k023558</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Amperometric</td><td rowspan=1 colspan=1>Photometric</td></tr><tr><td rowspan=1 colspan=1>Measuring Range</td><td rowspan=1 colspan=1>150-350 mg/dL</td><td rowspan=1 colspan=1>100-400 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Test Read Time</td><td rowspan=1 colspan=1>30 seconds</td><td rowspan=1 colspan=1>45 seconds</td></tr><tr><td rowspan=1 colspan=1>Sample VolumeApplication</td><td rowspan=1 colspan=1>Approximately 15 μL or 1 dropis added to the test spot</td><td rowspan=1 colspan=1>Approximately 135μL or 3drops are added to the test spot</td></tr><tr><td rowspan=1 colspan=1>Test</td><td rowspan=1 colspan=1>Cholesterol only</td><td rowspan=1 colspan=1>Lipid Panel</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

1) General Principles of Software Validation; Final Guidance for Industry and FDA Staff, FDA, January 11, 1997.

2) IEEE Standard 1012-1986, IEEE Standard for Software Verification and Validation Plans, The institute of Electrical and Electronic Engineers, Inc. 1997.

3) Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, Department of Health and Human Services, Food and Drug Administration, July 2000.

4) Quality Systems – Model for quality assurance in design, development, production, installation and servicing, ISO 9001:2000, International Organization for Standardization.

# L. Test Principle:

The Test Principle used by this device is enzyme electrochemical sensor technology. Biomedix’s biosensor uses a separate disposable dry reagent strip a for glucose and cholesterol determinations. When a drop of blood from the fingertip is applied to the halfcircle test spot on the glucose test strip or the circular test spot on the cholesterol test strip, the reduction and oxidation reaction causes electron transfer at the electrode surfaces. Current is generated and detected by the Q.STEPS Biometer $\mathrm { G } / \mathrm { C }$ Dual Monitoring System. The magnitude of the current generated is proportional to the analyte concentration in the blood.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility:

# Glucose

The sponsor indicated glucose spiked venous whole blood was used to perform the Within-Run Precision Study. Commercially purchased venous blood was pooled together and spun down to separate the erythrocytes from plasma. The venous blood was then adjusted to $45 \pm 3 \%$ hematocrit with the plasma. Five different concentrations of glucose spiked whole blood solutions were made by adding the concentrated glucose solution into the whole blood. These glucose spiked whole blood samples were used for the within-run precision study. Each sample was measured twice per day for 20 days. As shown in the table below, the values of C.V were between $2 . 7 \%$ and $8 . 0 \%$

Within-run precision results with venous whole blood on Biometer G/C   

<table><tr><td rowspan=1 colspan=1>Lot #</td><td rowspan=1 colspan=1>GlucoseConcentration(mg/dL) measuredby YSI</td><td rowspan=1 colspan=1>Total Numberof Samples (N)</td><td rowspan=1 colspan=3>Within RunMean by      Standard    CoefficientBiometer     Deviation   of Variation(mg/dL)         (mg/dL)         %</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>4.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>5.2</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>7.8</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>224</td><td rowspan=1 colspan=1>11.0</td><td rowspan=1 colspan=1>4.9</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>353</td><td rowspan=1 colspan=1>16.5</td><td rowspan=1 colspan=1>4.7</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>6.3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>91</td><td rowspan=1 colspan=1>7.3</td><td rowspan=1 colspan=1>8.0</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>7.8</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>217</td><td rowspan=1 colspan=1>13.9</td><td rowspan=1 colspan=1>6.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>372</td><td rowspan=1 colspan=1>10.3</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>4.9</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>84</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>2.6</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>6.6</td><td rowspan=1 colspan=1>2.7</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>16.8</td><td rowspan=1 colspan=1>4.2</td></tr></table>

The average within-run total variation coefficient with whole blood was between 3.75 and $5 . 8 6 \%$ .

# Summary results of within-run precision with whole blood.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>GlucoseConcentration(mg/dL)measured byYSI</td><td rowspan=1 colspan=1>Average Meanby BiometerG/C(mg/dL)</td><td rowspan=1 colspan=1>AverageStandardDeviation byBiometer G/C(mg/dL)</td><td rowspan=1 colspan=1>AverageCoefficient ofVariation[&lt;8%]%</td></tr><tr><td rowspan=1 colspan=1>All Three Lots</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>4.82</td></tr><tr><td rowspan=1 colspan=1>All Three Lots</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>5.86</td></tr><tr><td rowspan=1 colspan=1>All Three Lots</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>5.83</td></tr><tr><td rowspan=1 colspan=1>All Three Lots</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>4.63</td></tr><tr><td rowspan=1 colspan=1>All Three Lots</td><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>386</td><td rowspan=1 colspan=1>14.5</td><td rowspan=1 colspan=1>3.75</td></tr></table>

# Cholesterol

The specimens used in the precision study were EDTA preserved whole blood samples that were obtained commercially. First, the whole blood samples were pooled together, spun down and plasma removed. The serum-base cholesterol stock solutions with the desired cholesterol level were then mixed with red blood cells to become a whole blood sample. The cholesterol-spiked blood was prepared at four target concentrations of 190, 200, 240, and $2 6 0 \mathrm { m g / d L }$ . The venous blood was then adjusted to a final hematocrit of

$45 \%$ . $1 5 ~ \mu \mu 1$ of these blood samples were tested with the Q.STEPS Biometer G/C System, 20 times for each concentration. The values of within-run (average) total variation coefficient with whole blood were between 1.0 and $4 . 0 \%$ .

Whole blood precision   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>CholesterolConcentrationby Cobas(mg/dL)</td><td rowspan=1 colspan=1>TotalNumber ofSamples (n)</td><td rowspan=1 colspan=3>Within-runMean by       Standard       CoefficientBiometer      Deviation      of Variation(mg/dL)       (mg/dL)         %CV</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>190</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>185</td><td rowspan=1 colspan=1>6.11</td><td rowspan=1 colspan=1>3.30</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>210</td><td rowspan=1 colspan=1>7.32</td><td rowspan=1 colspan=1>3.49</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>238</td><td rowspan=1 colspan=1>7.94</td><td rowspan=1 colspan=1>3.33</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>260</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>258</td><td rowspan=1 colspan=1>4.87</td><td rowspan=1 colspan=1>1.89</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>190</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>196</td><td rowspan=1 colspan=1>4.08</td><td rowspan=1 colspan=1>2.08</td></tr><tr><td rowspan=1 colspan=1>[]</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>203</td><td rowspan=1 colspan=1>6.43</td><td rowspan=1 colspan=1>3.17</td></tr><tr><td rowspan=1 colspan=1>[]</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>230</td><td rowspan=1 colspan=1>5.33</td><td rowspan=1 colspan=1>2.32</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>260</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>263</td><td rowspan=1 colspan=1>5.30</td><td rowspan=1 colspan=1>2.01</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>190</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>181</td><td rowspan=1 colspan=1>7.35</td><td rowspan=1 colspan=1>4.05</td></tr><tr><td rowspan=1 colspan=1>[]</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>206</td><td rowspan=1 colspan=1>8.35</td><td rowspan=1 colspan=1>4.06</td></tr><tr><td rowspan=1 colspan=1>[]</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>226</td><td rowspan=1 colspan=1>8.71</td><td rowspan=1 colspan=1>3.85</td></tr><tr><td rowspan=1 colspan=1>[]</td><td rowspan=1 colspan=1>260</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>270</td><td rowspan=1 colspan=1>6.59</td><td rowspan=1 colspan=1>2.44</td></tr></table>

The sponsor determined the within run and day-to-day precision on the Q.STEPS System using Standard Cholesterol Solutions at $2 0 0 \mathrm { m g / d L }$ and $2 4 0 \mathrm { m g / d L }$ . $2 5 \mu \mathrm { l }$ of the standard solution was applied to two test strips per concentration. Readings were taken twice per day for 10 consecutive days. Three different lots of test strips were tested. The within-run C.V. varied form $1 . 9 5 \%$ to $2 . 4 7 \%$

Within-run precision results of Q.STEPS $\mathbf { G } / \mathbf { C }$ with serum specimen   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>CholesterolConcentration</td><td rowspan=1 colspan=1>TotalNumber</td><td rowspan=1 colspan=1>Meanmg/dL</td><td rowspan=1 colspan=2>Within-runSD  %CV</td><td rowspan=1 colspan=1>Betweenrun</td><td rowspan=1 colspan=2>TotalprecisionSD  %CV</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>202</td><td rowspan=1 colspan=1>4.97</td><td rowspan=1 colspan=1>2.47</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>6.27</td><td rowspan=1 colspan=1>3.11</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>243</td><td rowspan=1 colspan=1>5.34</td><td rowspan=1 colspan=1>2.19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>6.00</td><td rowspan=1 colspan=1>2.47</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>202</td><td rowspan=1 colspan=1>4..49</td><td rowspan=1 colspan=1>2.22</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5.91</td><td rowspan=1 colspan=1>2.93</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>242</td><td rowspan=1 colspan=1>4.88</td><td rowspan=1 colspan=1>2.02</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5.46</td><td rowspan=1 colspan=1>2.26</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>203</td><td rowspan=1 colspan=1>4.45</td><td rowspan=1 colspan=1>2.19</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5.59</td><td rowspan=1 colspan=1>2.75</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>243</td><td rowspan=1 colspan=1>4.71</td><td rowspan=1 colspan=1>1.95</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>5.13</td><td rowspan=1 colspan=1>2.12</td></tr></table>

# Clinical Sites Precision Studies

Venous whole blood samples were collected from patients at three different clinical trial sites. $1 5 \mu \mathrm { l }$ of the whole blood was applied to each cholesterol test strip. Each blood sample was applied 20 times.

Precision data obtained from clinical sites   

<table><tr><td rowspan=1 colspan=1>Location</td><td rowspan=1 colspan=1>Total numberof samples (n)</td><td rowspan=1 colspan=3>Within-runMean               SD               CV(mg/dL)                (mg/dL)           %</td></tr><tr><td rowspan=2 colspan=1>Site 1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>192</td><td rowspan=1 colspan=1>5.91</td><td rowspan=1 colspan=1>3.08</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>239</td><td rowspan=1 colspan=1>6.38</td><td rowspan=1 colspan=1>2.67</td></tr><tr><td rowspan=2 colspan=1>Site 2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>209</td><td rowspan=1 colspan=1>6.02</td><td rowspan=1 colspan=1>2.89</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>239</td><td rowspan=1 colspan=1>5.15</td><td rowspan=1 colspan=1>2.15</td></tr><tr><td rowspan=2 colspan=1>Site 3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>206</td><td rowspan=1 colspan=1>6.35</td><td rowspan=1 colspan=1>3.09</td></tr><tr><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>241</td><td rowspan=1 colspan=1>6.86</td><td rowspan=1 colspan=1>2.85</td></tr></table>

# b. Linearity/assay reportable range:

# Glucose

The sponsor pooled $9 8 0 \mu \mathrm { l }$ of venous blood and adjusted the hematocrit to $45 \% \pm 3$ . The pooled sample was then spiked with a Glucose stock solution resulting in blood glucose concentrations of $2 5 \mathrm { m g / d L }$ , $5 0 \mathrm { m g / d L }$ , $1 0 0 \mathrm { m g / d L }$ , $2 0 0 \mathrm { m g / d L }$ $3 0 0 \mathrm { m g / d L }$ , $4 0 0 \mathrm { m g / d L }$ , $5 0 0 \mathrm { m g / d L }$ , $5 5 0 \mathrm { m g / d L }$ and $6 0 0 \mathrm { m g / d L }$ . Each sample was then measured by the YSI STAT PLUS analyzer, as a reference, and then $1 0 ~ \mu \mu 1$ of the sample was placed on the Q.STEPS Side Sensor Test Strip and Biometer $\mathrm { G } / \mathrm { C }$ . Each concentration level of whole blood glucose spiked solution was applied to four test strips. The average reading was taken for the measurements.

# Results

For each lot of test strips, the glucose concentration determined by the Q.STEPS Biometer $\mathrm { G } / \mathrm { C }$ was plotted against the glucose concentration determined by the YSI 2300

# Linearity studies of whole blood

<table><tr><td rowspan=1 colspan=1>Lot #</td><td rowspan=1 colspan=1>Tested Range</td><td rowspan=1 colspan=1>$R^{r}$</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-400 mg/dL</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=1>1.025</td><td rowspan=1 colspan=1>3.9</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>25-600 mg/dL</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>1.192</td><td rowspan=1 colspan=1>-13</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>25-600 mg/dL</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=1>1.033</td><td rowspan=1 colspan=1>-2.6</td></tr></table>

# Cholesterol

The sponsor spiked $1 5 \mu 1$ of venous blood with cholesterol stock solutions resulting in blood cholesterol concentrations of $1 5 0 \mathrm { m g / d L }$ , $2 0 0 \mathrm { m g / d L }$ , $2 4 0 \mathrm { m g / d L }$ , $3 0 0 \mathrm { m g / d L }$ and $3 5 0 \mathrm { m g / d L }$ . The cholesterol concentration of each sample was first measured by the Cobas Mira PLUS, as a reference, and then $1 5 \mu \mu 1$ of the sample was placed on the Q.STEPS Cholesterol Test Strip and the Biometer $\mathrm { G } / \mathrm { C }$ . Each level of whole blood cholesterol spiked solution was applied to four test strips. The average readings were taken for the measurement of linear regression.

# Results

For each lot of test strips, the Cholesterol concentration determined by the Q.STEPS Biometer was plotted against the Cholesterol concentration determined by the Cobas Mira PLUS.

# Linearity studies of whole blood

<table><tr><td rowspan=1 colspan=1>Lot #</td><td rowspan=1 colspan=1>Tested Range</td><td rowspan=1 colspan=1>$R^{}$</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>150-350 mg/dL</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>1.03</td><td rowspan=1 colspan=1>-6.47</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>150-350 mg/dL</td><td rowspan=1 colspan=1>0.99</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>-0.09</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>150-350 mg/dL</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>1.05</td><td rowspan=1 colspan=1>-15.76</td></tr></table>

c. Traceability (controls, calibrators, or method):

The traceability of the Glucose and Cholesterol calibrators and controls are verified against commercially available Standard Reference Material from the National Institute of Standards and Technology (formerly NBS).

1. Commercially available (serum based) Standard Cholesterol Solutions   
2. “Current Status of Blood Cholesterol Measurement in Clinical Laboratories in the United States: A report from the Laboratory Standardization Panel of the National Cholesterol Education Program”. Clin. Chem 34/1, 1998, 193-201.   
3. “Recommendations for Improving Cholesterol Measurement: A report from the Laboratory Standardization Panel of the National Cholesterol Education Program”. NIH Publication No. 90-2964, February 1990.

d. Detection limit:

Glucose 50 – 400 mg/dL

Cholesterol 150 – 350 mg/dL e. Analytical specificity:

# Glucose

According to the sponsor twenty-three commonly tested interferent substances were examined. No interference was observed in bilirubin, creatinine and citrate at physiological levels. Based on the tested concentrations, 4-acetamidophenol, ascorbic acid, dopamine, L-Dopa, Ibuprofen, methyldopa, and uric acid interfered with some glucose measurements.

Tested interference substances, concentrations, and their effects.

<table><tr><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>PhysiologicalTherapeuticLevels(mg/dL)</td><td rowspan=1 colspan=1>Toxic(mg/dL)</td><td rowspan=1 colspan=1>SubstanceTestedConc.(mg/dL)</td><td rowspan=1 colspan=1>InterferenceAt Glucose80mg/dL</td><td rowspan=1 colspan=1>InterferenceAt Glucose200 mg/dL)</td><td rowspan=1 colspan=1>Effect oflow glucconc.(80mg/dL)</td><td rowspan=1 colspan=1>Effectof highglucconc.(200mg/dL)</td></tr><tr><td rowspan=1 colspan=1>4Acetamindophenol</td><td rowspan=1 colspan=1>1.0-2.0</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2.0-6.0</td><td rowspan=1 colspan=1>No interup to2.0mg/dL</td><td rowspan=1 colspan=1>No interup to4.0mg/dL</td><td rowspan=1 colspan=1>▲</td><td rowspan=1 colspan=1>▲</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>0.8-1.2</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>1.0-4.0</td><td rowspan=1 colspan=1>No interup to2.0mg/dL</td><td rowspan=1 colspan=1>Inter at1.0mg/dL</td><td rowspan=1 colspan=1>▼</td><td rowspan=1 colspan=1>▼</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>0.1-1.2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>6.8-20</td><td rowspan=1 colspan=1>No interup to 20mg/dL</td><td rowspan=1 colspan=1>No interup to 20mg/dL</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>&lt;200</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>—</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>Citrate sodium salt</td><td rowspan=1 colspan=1>1.7-3.0</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>8.9-26.6</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>一</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>0.6-1.2</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>21.9-65.7</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>—</td><td rowspan=1 colspan=1>一</td></tr><tr><td rowspan=1 colspan=1>Dextrin</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0.1-0.2</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>L-Dopa</td><td rowspan=1 colspan=1>0.02-0.03</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0.23-6.9</td><td rowspan=1 colspan=1>No interup to2.3mg/dL</td><td rowspan=1 colspan=1>No interup to2.3mg/dL</td><td rowspan=1 colspan=1>▲</td><td rowspan=1 colspan=1>▲</td></tr><tr><td rowspan=1 colspan=1>Dopamine</td><td rowspan=1 colspan=1>0.4-1.6</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0.02-2.6</td><td rowspan=1 colspan=1>No interup to0.7mg/dL</td><td rowspan=1 colspan=1>No interup to0.52mg/dL</td><td rowspan=1 colspan=1>▲</td><td rowspan=1 colspan=1>▲</td></tr><tr><td rowspan=1 colspan=1>EDTA</td><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>100-400</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>D-Galactose</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>22.1-66.2</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>0.5-4.2</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>27-81</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No interup to 54mg/dL</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>√</td></tr><tr><td rowspan=1 colspan=1>K3Fe(CN)6</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>2.86</td><td rowspan=1 colspan=1>0.2-0.5</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>—</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>Maltose</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>18-54</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>—</td><td rowspan=1 colspan=1>一</td></tr><tr><td rowspan=1 colspan=1>D-Mannose</td><td rowspan=1 colspan=1>5.0-7.5mg/day</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>10-30</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>—</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>Mega8</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0.2-0.5</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>_</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Methyldopa</td><td rowspan=1 colspan=1>0.1-0.5</td><td rowspan=1 colspan=1>&gt;1.0</td><td rowspan=1 colspan=1>1.2-3.5</td><td rowspan=1 colspan=1>No interup to2.0mg/dL</td><td rowspan=1 colspan=1>No interup to1.0mg/dL</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>▼</td></tr><tr><td rowspan=1 colspan=1>Salicylic acid</td><td rowspan=1 colspan=1>15-30</td><td rowspan=1 colspan=1>&gt;40</td><td rowspan=1 colspan=1>8.7-</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>√</td><td rowspan=1 colspan=1>√</td></tr></table>

Page 11 of 16   

<table><tr><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>PhysiologicalTherapeuticLevels(mg/dL)</td><td rowspan=1 colspan=1>Toxic(mg/dL)</td><td rowspan=1 colspan=1>SubstanceTestedConc.(mg/dL)</td><td rowspan=1 colspan=1>InterferenceAt Glucose80mg/dL</td><td rowspan=1 colspan=1>InterferenceAt Glucose200mg/dL)</td><td rowspan=1 colspan=1>Effect oflow glucconc.(80mg/dL)</td><td rowspan=1 colspan=1>Effectof highglucconc.(200mg/dL)</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>26.1</td><td rowspan=1 colspan=1>up to 25mg/dL</td><td rowspan=1 colspan=1>up to 50mg/dL</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Tetracycline</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>1.8-5.4</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>一</td><td rowspan=1 colspan=1>一</td></tr><tr><td rowspan=1 colspan=1>Tolazamide</td><td rowspan=1 colspan=1>2.0-2.5</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>1.6-5.4</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>一</td><td rowspan=1 colspan=1>—</td></tr><tr><td rowspan=1 colspan=1>Triglyceride</td><td rowspan=1 colspan=1>&lt;190</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>100-300</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>一</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>M: 2.1-7.8F: 2.0-6.4</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>2.7-8.1</td><td rowspan=1 colspan=1>No interup to2.7mg/dL</td><td rowspan=1 colspan=1>No interup to5.4mg/dL</td><td rowspan=1 colspan=1>▲</td><td rowspan=1 colspan=1>▲</td></tr><tr><td rowspan=1 colspan=1>D-Xylose</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>15.3-45.9</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>No inter</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>-</td></tr></table>

# Cholesterol

The sponsor tested ten common endogenous or exogenous substances for cholesterol meters. Hemoglobin was also tested due to the occurrence of hemolyzed specimens. The sponsor utilized a Student t test for statistical analysis. Paired differences were analyzed to determine statistically significant differences between 3 lots of cholesterol test strips. A p value less than .05 was considered to be statistically significant. The therapeutic and toxic concentrations of the interferents are listed in the below table.

Tested interference substances, concentrations, and their effects.   

<table><tr><td colspan="1" rowspan="1">Substance</td><td colspan="1" rowspan="1">PhysiologicalTherapeuticLevels(mg/dL)</td><td colspan="1" rowspan="1">Toxic(mg/dL)</td><td colspan="1" rowspan="1">SubstanceTestedConc.(mg/dL)</td><td colspan="1" rowspan="1">InterferenceAt Chol200mg/dL</td><td colspan="1" rowspan="1">InterferenceAt Chol240 mg/dL)</td><td colspan="1" rowspan="1">Effectof lowcholconc.(200mg/dL)</td><td colspan="1" rowspan="1">Effectof highcholconc.(240mg/dL)</td></tr><tr><td colspan="1" rowspan="1">4Acetamindophenol</td><td colspan="1" rowspan="1">1.0-2.0</td><td colspan="1" rowspan="1">&gt;15</td><td colspan="1" rowspan="1">1.5-6.0</td><td colspan="1" rowspan="1">No interup to 3.0mg/dL</td><td colspan="1" rowspan="1">No interup to 3.0mg/dL</td><td colspan="1" rowspan="1">▲</td><td colspan="1" rowspan="1">▲</td></tr><tr><td colspan="1" rowspan="1">Ascorbic Acid</td><td colspan="1" rowspan="1">0.8-1.2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">1.0-4.0</td><td colspan="1" rowspan="1">No interup to 2.0mg/dL</td><td colspan="1" rowspan="1">Inter at1.0mg/dL</td><td colspan="1" rowspan="1">√</td><td colspan="1" rowspan="1">▼</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">0.1-1.2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">6.8-20</td><td colspan="1" rowspan="1">No interup to 20mg/dL</td><td colspan="1" rowspan="1">No interup to 20mg/dL</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Dopamine</td><td colspan="1" rowspan="1">0.4-1.6</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">0.02-2.6</td><td colspan="1" rowspan="1">No interup to 8.0mg/dL</td><td colspan="1" rowspan="1">No interup to 4.0</td><td colspan="1" rowspan="1">▼</td><td colspan="1" rowspan="1">▼</td></tr><tr><td colspan="1" rowspan="1">EDTA</td><td colspan="1" rowspan="1">61</td><td colspan="1" rowspan="1">240</td><td colspan="1" rowspan="1">100-</td><td colspan="1" rowspan="1">No inter</td><td colspan="1" rowspan="1">No inter</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">_</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">up to400mg/dL</td><td colspan="1" rowspan="1">up to400mg/dL</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">10 mg/dL</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">22.1-66.2</td><td colspan="1" rowspan="1">No interup to200mg/dL</td><td colspan="1" rowspan="1">No interup to200mg/dL</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">0.5-4.2</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">27-81</td><td colspan="1" rowspan="1">No interup to 10mg/dL</td><td colspan="1" rowspan="1">No interup to 20mg/dL</td><td colspan="1" rowspan="1">▲</td><td colspan="1" rowspan="1">▲</td></tr><tr><td colspan="1" rowspan="1">Methyldopa</td><td colspan="1" rowspan="1">0.1-0.5</td><td colspan="1" rowspan="1">&gt;1.0</td><td colspan="1" rowspan="1">1.2-3.5</td><td colspan="1" rowspan="1">No interup to 2.0mg/dL</td><td colspan="1" rowspan="1">No interup to 1.0mg/dL</td><td colspan="1" rowspan="1">▼</td><td colspan="1" rowspan="1">▼</td></tr><tr><td colspan="1" rowspan="1">Salicylic acid</td><td colspan="1" rowspan="1">15-30</td><td colspan="1" rowspan="1">&gt;40</td><td colspan="1" rowspan="1">8.7-26.1</td><td colspan="1" rowspan="1">No interup to 25mg/dL</td><td colspan="1" rowspan="1">No interup to 50mg/dL</td><td colspan="1" rowspan="1">▼</td><td colspan="1" rowspan="1">▼</td></tr><tr><td colspan="1" rowspan="1">Triglyceride</td><td colspan="1" rowspan="1">&lt;190</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">475-1900</td><td colspan="1" rowspan="1">No interup to1900mg/dL</td><td colspan="1" rowspan="1">No interup to1900mg/dL</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Uric Acid</td><td colspan="1" rowspan="1">M: 2.1-7.8F: 2.0- 6.4</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">5.0-20.0</td><td colspan="1" rowspan="1">No interup to10.0mg/dL</td><td colspan="1" rowspan="1">No interup to 5.0mg/dL</td><td colspan="1" rowspan="1">▼</td><td colspan="1" rowspan="1">c:</td></tr></table>

# Hematocrit Study Glucose

The sponsor obtained venous whole blood samples that were pooled, and then spun down to separate the red cells from the plasma. The plasma was adjusted to the desired target hematocrit concentration levels of approximately $20 \%$ , $2 5 \%$ , $30 \%$ , $40 \%$ , $45 \%$ , $50 \%$ , and $60 \%$ . Each hematocrit level had 5 target glucose concentrations $( 5 0 \mathrm { m g / d L }$ , $8 0 \mathrm { m g / d L }$ , $1 2 0 \mathrm { m g / d L }$ , $2 0 0 \mathrm { m g / d L }$ and $4 0 0 \mathrm { m g / d L }$ ), which were prepared by spiking with appropriate volumes of glucose stock solutions.

The sponsor’s acceptance criteria for this study was determined to be hematocrit levels that exhibit glucose concentrations within $\pm 2 0 \%$ of that glucose reading of the same specimen at $45 \%$ hematocrit level.

<table><tr><td rowspan=1 colspan=1>GlucoseConc.(mg/dL)</td><td rowspan=1 colspan=8>Hematocrit Percent Levels</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>20%</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>30%</td><td rowspan=1 colspan=1>35%</td><td rowspan=1 colspan=1>40%</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>55%</td><td rowspan=1 colspan=1>60%</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>16.1</td><td rowspan=1 colspan=1>19.7</td><td rowspan=1 colspan=1>12.7</td><td rowspan=1 colspan=1>8.1</td><td rowspan=1 colspan=1>-0.7</td><td rowspan=1 colspan=1>-6.4</td><td rowspan=1 colspan=1>-19.7</td><td rowspan=1 colspan=1>-22.1</td></tr><tr><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>25.3</td><td rowspan=1 colspan=1>14.5</td><td rowspan=1 colspan=1>19.6</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>-2.2</td><td rowspan=1 colspan=1>-9.8</td><td rowspan=1 colspan=1>-7.3</td><td rowspan=1 colspan=1>-7.4</td></tr><tr><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>21.7</td><td rowspan=1 colspan=1>11.4</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>-3.7</td><td rowspan=1 colspan=1>-9.7</td><td rowspan=1 colspan=1>-10.2</td><td rowspan=1 colspan=1>-18.5</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>22.9</td><td rowspan=1 colspan=1>23.0</td><td rowspan=1 colspan=1>14.2</td><td rowspan=1 colspan=1>-1.3</td><td rowspan=1 colspan=1>-2.7</td><td rowspan=1 colspan=1>-1.4</td><td rowspan=1 colspan=1>-7.0</td><td rowspan=1 colspan=1>-17.7</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>-4.7</td><td rowspan=1 colspan=1>-3.0</td><td rowspan=1 colspan=1>4.7</td><td rowspan=1 colspan=1>-0.3</td><td rowspan=1 colspan=1>-7.2</td><td rowspan=1 colspan=1>-11.0</td><td rowspan=1 colspan=1>-18.2</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=8>Hematocrit Percentt Levels</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>20.9</td><td rowspan=1 colspan=1>27.4</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1>6.9</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>-2.5</td><td rowspan=1 colspan=1>-5.9</td><td rowspan=1 colspan=1>-10.0</td></tr><tr><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>8.5</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>-5.6</td><td rowspan=1 colspan=1>-8.0</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>-8.3</td></tr><tr><td rowspan=1 colspan=1>120</td><td rowspan=1 colspan=1>13.5</td><td rowspan=1 colspan=1>11.6</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>-2.0</td><td rowspan=1 colspan=1>-10.1</td><td rowspan=1 colspan=1>-15.9</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>11.3</td><td rowspan=1 colspan=1>15.3</td><td rowspan=1 colspan=1>11.1</td><td rowspan=1 colspan=1>7.2</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>-5.3</td><td rowspan=1 colspan=1>-14.4</td><td rowspan=1 colspan=1>-14.5</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>-11.7</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>7.8</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>-4.0</td><td rowspan=1 colspan=1>-5.7</td><td rowspan=1 colspan=1>-11.1</td></tr></table>

# Cholesterol

The sponsor obtained venous whole blood samples that were pooled, and then spun down to separate the red cells from the plasma. The plasma was adjusted to the desired target hematocrit concentration levels of approximately $20 \%$ , $2 5 \%$ , $30 \%$ , $40 \%$ , $45 \%$ , $50 \%$ , and $60 \%$ . Each hematocrit level had 2 target cholesterol concentrations (200 and $2 4 0 \mathrm { m g / d L }$ , which were prepared by spiking with appropriate volumes of cholesterol stock solutions. $1 5 \mu 1$ of the adjusted whole blood sample was applied to the cholesterol test strips. The data is presented below.

# Percent difference in hematocrit

<table><tr><td rowspan=1 colspan=1>CholesterolConc.(mg/dL)</td><td rowspan=1 colspan=8>Hematocrit Percent Levels</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>20%</td><td rowspan=1 colspan=1>25%</td><td rowspan=1 colspan=1>30%</td><td rowspan=1 colspan=1>35%</td><td rowspan=1 colspan=1>40%</td><td rowspan=1 colspan=1>50%</td><td rowspan=1 colspan=1>55%</td><td rowspan=1 colspan=1>60%</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>13.4</td><td rowspan=1 colspan=1>13.4</td><td rowspan=1 colspan=1>11.5</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>-12.4</td></tr><tr><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>22.1</td><td rowspan=1 colspan=1>22.1</td><td rowspan=1 colspan=1>13.7</td><td rowspan=1 colspan=1>7.7</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>-2.6</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>-11.6</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=8>Hematocrit Percent Levels</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>20.5</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>15.0</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>-5.0</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>-10.3</td></tr><tr><td rowspan=1 colspan=1>240</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>-2.9</td><td rowspan=1 colspan=1>-6.7</td><td rowspan=1 colspan=1>-10.0</td></tr></table>

$f .$ Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device:

# Glucose

Method comparison studies were performed at three different clinical sites. The correlation studies were made between the Biometer (k050182) new device, One Touch (k031472) predicate device, and the YSI (reference method) utilizing finger stick whole blood samples. The sponsor indicated that each home user performed their own fingerstick and performed the test on the Q.STEPS Biometer $\mathrm { G } / \mathrm { C }$ . The measurement was also read by the professionals.

The professionals then performed another fingerstick on the same home user and performed a glucose test on the same device with the same lot of test strips. All of the results were masked from each other. The professional then tested the same user with the One Touch and YSI methods. The comparison results are presented the table below. The results are expressed as the mean absolute bias and regression analysis.

Comparison of fingertip whole blood results from three different clinical sites.   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>TestStrip Lot#</td><td rowspan=1 colspan=1>ResultsComparisons</td><td rowspan=1 colspan=1>TotalPatientsTested</td><td rowspan=1 colspan=1>Mean ofAbsoluteBias (%)</td><td rowspan=1 colspan=1>RegressionAnalysisSlope</td><td rowspan=1 colspan=1>RegressionAnalysisIntercept</td><td rowspan=1 colspan=1>RegressionAnalysisCoefficientVariation(r)</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 1)</td><td rowspan=4 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Home User vs.YSI</td><td rowspan=1 colspan=1>171</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>3.12</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>Home User vs.Professional</td><td rowspan=1 colspan=1>171</td><td rowspan=1 colspan=1>6.6</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>-0.98</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>Professional vs.PredicateDevice (OneTouch)</td><td rowspan=1 colspan=1>175</td><td rowspan=1 colspan=1>9.3</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>15.03</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=1 colspan=1>Professional vs.YSI</td><td rowspan=1 colspan=1>163</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>8.15</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 2)</td><td rowspan=4 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Home User vs.YSI</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>9.5</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>-1.59</td><td rowspan=1 colspan=1>0.93</td></tr><tr><td rowspan=1 colspan=1>Home User vs.Professional</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>7.8</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>-1.01</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=1 colspan=1>Professional vs.PredicateDevice (OneTouch)</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>0.98</td><td rowspan=1 colspan=1>5.8</td><td rowspan=1 colspan=1>0.92</td></tr><tr><td rowspan=1 colspan=1>Professional vs.YSI</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>7.7</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 3)</td><td rowspan=4 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Home User vs.YSI</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>7.7</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>4.07</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>Home User vs.Professional</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>5.4</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>-1.44</td><td rowspan=1 colspan=1>0.96</td></tr><tr><td rowspan=1 colspan=1>Professional vs.PredicateDevice (OneTouch)</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>8.7</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>10.12</td><td rowspan=1 colspan=1>0.94</td></tr><tr><td rowspan=1 colspan=1>Professional vs.YSI</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>6.39</td><td rowspan=1 colspan=1>0.95</td></tr></table>

# Cholesterol

Method comparison studies were compared with the Abel-Kendall reference method performed in a CDC- certified Cholesterol Reference Method Network Laboratory (CRMLN). The Abell-Kendall method is performed with serum only. External studies were also done at three different clinical sites by Lay-users. A total of 456 patients from the three different sites participated in the clinical trial.

The lay-users performed their fingerstick and performed the cholesterol test on the Q.STEPS Biometer $\mathrm { G } / \mathrm { C }$ System and the results were recorded by the lay-user and professional. The professional also performed a finger stick cholesterol test on the same lay-user using the same Biometer $\mathrm { G } / \mathrm { C }$ System with the same lot of test strips. The professional from each site also drew a tube of venous blood from 14-16 layusers in order to send the serum to CRMLN for comparison. Comparison results are presented in the table below.

Comparison Results from Three Different Clinical Sites   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>TestStripLot#</td><td rowspan=1 colspan=1>ResultsComparisons</td><td rowspan=1 colspan=1>TotalPatientsTested</td><td rowspan=1 colspan=1>RegressionAnalysisSlope</td><td rowspan=1 colspan=1>RegressionAnalysisIntercept</td><td rowspan=1 colspan=1>RegressionAnalysisCoefficientVariation(r)</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 1)</td><td rowspan=4 colspan=1>Lot1</td><td rowspan=1 colspan=1>Home User Performed /Read vs. ProfessionalPerformed/ Read</td><td rowspan=1 colspan=1>195</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>13.57</td><td rowspan=1 colspan=1>0.93</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. Home UserPerformed/ Read</td><td rowspan=1 colspan=1>195</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. CRMLN</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>15.10</td><td rowspan=1 colspan=1>0.92</td></tr><tr><td rowspan=1 colspan=1>ProfessionalPerformed/ Read vs.CRMLN</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0.87</td><td rowspan=1 colspan=1>26.15</td><td rowspan=1 colspan=1>0.91</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 2)</td><td rowspan=4 colspan=1>Lot2</td><td rowspan=1 colspan=1>Home User Performed /Read vs. ProfessionalPerformed/ Read</td><td rowspan=1 colspan=1>146</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>-1.84</td><td rowspan=1 colspan=1>0.95</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. Home UserPerformed/ Read</td><td rowspan=1 colspan=1>146</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. CRMLN</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>11.15</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>ProfessionalPerformed/ Read vs.CRMLN</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>17.51</td><td rowspan=1 colspan=1>0.97</td></tr><tr><td rowspan=4 colspan=1>PhysicianOffice(Site 3)</td><td rowspan=4 colspan=1>Lot3</td><td rowspan=1 colspan=1>Home User Performed /Read vs. ProfessionalPerformed/ Read</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>0.91</td><td rowspan=1 colspan=1>16.59</td><td rowspan=1 colspan=1>0.91</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. Home UserPerformed/ Read</td><td rowspan=1 colspan=1>115</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>Home User Performed/Read vs. CRMLN</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>0.94</td><td rowspan=1 colspan=1>16.55</td><td rowspan=1 colspan=1>0.98</td></tr><tr><td rowspan=1 colspan=1>ProfessionalPerformed/ Read vs.CRMLN</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>0.95</td><td rowspan=1 colspan=1>19.09</td><td rowspan=1 colspan=1>0.98</td></tr></table>

The bias between the CRMLN and Q.STEPS Biometer $\mathrm { G } / \mathrm { C }$ Dual Monitoring System at the medical decision points of $2 0 0 \mathrm { m g / d L }$ and $2 4 0 \mathrm { m g / d L }$ , about $4 . 6 5 \%$ were positively misclassified and $2 . 3 3 \%$ were negatively classified.

b. Matrix comparison: Not Applicable

3. Clinical studies: a. Clinical sensitivity:

See above

b. Clinical specificity:   
See above   
c. Other clinical supportive data (when a and b are not applicable): See Comparison Studies referenced above.

4. Clinical cut-off: Not Applicable

# 5. Expected values/Reference range:

Glucose Patient glucose ranges for non-diabetic, non-pregnant adults:

<table><tr><td rowspan=1 colspan=2>Glucose fasting</td><td rowspan=1 colspan=1>70 mg/dL – 110 mg/dL3.9 mmol/L – 6.1 mmol/L</td></tr><tr><td rowspan=1 colspan=1>1 hour after meal</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>&lt; 160 mg/dL (&lt;8.9 mmol/L)</td></tr></table>

1. Krall, LP and Deaser, RS: Joslin Diabetes Manual. Lea and Febiger. (1989) 138.

# Cholesterol

According to NCEP classification, patient cholesterol ranges for non-diabetic, nonpregnant adults1:

<table><tr><td rowspan=1 colspan=1>Desirable blood cholesterol</td><td rowspan=1 colspan=1>&lt;200 mg/dL (&lt;5.17 mmol/L)</td></tr><tr><td rowspan=1 colspan=1>Borderline-high blood cholesterol</td><td rowspan=1 colspan=1>200 mg/dL -239 mg/dL(5.17 mmol/L – 6.18 mmol/L)</td></tr><tr><td rowspan=1 colspan=1>High blood cholesterol</td><td rowspan=1 colspan=1>&gt;240 mg/dL (&gt;6.21 mmol/L)</td></tr></table>

1. National Cholesterol Education Program. Summary of the Second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel II). JAMA 1993; 269:3015-23 Davidsohn & Henry, Clinical Diagnosis by Laboratory Methods. Todd-Sandford.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.